胸段硬膜外导管与持续外周输注用于创伤性肋骨骨折疼痛管理的比较
该研究回顾性分析2018年1月至2020年12月一家一级创伤中心收治的1647例创伤性肋骨骨折患者,比较仅用胸段硬膜外导管(TEC)与仅用氯胺酮和/或利多卡因持续外周输注(drip only)两组。多变量线性混合效应模型显示,TEC组具有节省阿片类药物的时间依赖性剂量反应关系,第3天(27.4 vs 36.5 MME)和第4天(27.3 vs 36.2 MME)最明显(p < 0.01)。仅输注组的平均疼痛评分是仅TEC组的1.21倍(p < 0.001)。作者认为仅输注镇痛与更高的每日MME使用和MPS相关,TEC治疗的最大获益似乎在第3、4天,并指出需要前瞻性随机对照比较来评估治疗效果的大小。
要点
- 回顾性分析1647例创伤性肋骨骨折患者,仅用TEC组相比仅用持续外周输注组具有节省阿片类药物的效应,第3天27.4 vs 36.5 MME、第4天27.3 vs 36.2 MME(p < 0.01)。
- 仅输注组的平均疼痛评分是仅TEC组的1.21倍(p < 0.001)。
- TEC治疗的阿片节省获益似乎在第3、4天最明显。
- 作者指出需要前瞻性随机对照比较来评估治疗效果的大小。
适用人群与场景
- 2018年1月至2020年12月一家一级创伤中心收治的创伤性肋骨骨折患者,共1647例。
- 比较仅用胸段硬膜外导管(TEC only)与仅用氯胺酮和/或利多卡因持续外周输注(drip only)两组。
研究设计与关键结果
- 研究类型:回顾性分析,单中心(一家一级创伤中心),纳入2018年1月至2020年12月创伤性肋骨骨折入院患者1647例。
- 干预与对照:仅用胸段硬膜外导管(TEC only) vs 仅用氯胺酮和/或利多卡因持续外周输注(drip only)。
- 主要终点:采用线性混合效应模型评估每日吗啡毫克当量(MME)与治疗组的关联,纳入治疗组×时间(第1-7天)交互项;多变量分析后发现治疗组与MME之间存在显著的时间依赖性剂量反应关系,提示仅TEC组具有节省阿片类药物的效应。
- 阿片节省获益在仅TEC组第3天(27.4 vs 36.5 MME)和第4天(27.3 vs 36.2 MME)最明显(p < 0.01)。
- 采用零膨胀泊松混合效应模型评估治疗与平均疼痛评分(MPS)的关联;仅输注组的MPS是仅TEC组的1.21倍(p < 0.001)。
- 两个模型均校正了混杂因素。
证据类型、等级与局限
- 证据类型:回顾性分析;证据等级:治疗/护理管理;Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,与仅用TEC相比,仅输注镇痛与更高的每日MME使用和MPS相关;TEC治疗的最大获益似乎在第3、4天。
- 作者指出,需要前瞻性随机对照比较来评估治疗效果的大小。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Thoracic epidural catheters (TECs) are useful adjuncts to multimodal pain regimens in traumatic rib fractures. However, TEC placement is limited by contraindications, patient risk profile, and provider availability. Continuous peripheral infusion of ketamine and/or lidocaine is an alternative that has a modest risk profile and few contraindications. We hypothesized that patients with multiple traumatic rib fractures receiving TECs would have better pain control, in terms of daily morphine milligram equivalents (MMEs) and mean pain scores (MPSs) when compared with continuous peripheral infusions of ketamine and/or lidocaine.
METHODS: We retrospectively analyzed traumatic rib fracture admissions to a level 1 trauma center between January 2018 and December 2020. We evaluated two treatment groups: TEC only and continuous infusion only (drip only). A linear mixed-effects model evaluated the association of MME with treatment group. An interaction term of treatment group by time (days 1-7) was included to allow estimating potential time-dependent treatment effect on MME. A zero-inflated Poisson mixed-effects model evaluated the association of treatment with MPS. Both models adjusted for confounders.
RESULTS: A total of 1,647 patients were included. After multivariable analysis, a significant, time-varying dose-response relationship between treatment group and MME was found, indicating an opioid-sparing effect favoring the TEC-only group. The opioid-sparing benefit for TEC-only therapy was most prominent at day 3 (27.4 vs 36.5 MME) and day 4 (27.3 vs 36.2 MME) ( p < 0.01). The drip-only group had 1.21 times greater MPS than patients with TEC only ( p < 0.001).
CONCLUSION: Drip-only analgesia is associated with higher daily MME use and MPS, compared with TEC only. The maximal benefit of TEC therapy appears to be on days 3 and 4. Prospective, randomized comparison between groups is necessary to evaluate the magnitude of the treatment effect.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Beyene RT, Wallace MW, Statzer N, et al. Comparison of thoracic epidural catheter and continuous peripheral infusion for management of traumatic rib fracture pain. J Trauma Acute Care Surg. 2024. PMID: 39269315. doi:10.1097/TA.0000000000004445
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。